299 related articles for article (PubMed ID: 7518280)
1. New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase.
van der Wilt CL; Peters GJ
Pharm World Sci; 1994 Apr; 16(2):84-103. PubMed ID: 7518280
[TBL] [Abstract][Full Text] [Related]
2. The role of pemetrexed in the treatment of colorectal cancer.
Hochster H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
[TBL] [Abstract][Full Text] [Related]
3. New concepts for the development and use of antifolates.
Chu E; Grem JL; Johnston PG; Allegra CJ
Stem Cells; 1996 Jan; 14(1):41-6. PubMed ID: 8820950
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.
Rustum YM; Harstrick A; Cao S; Vanhoefer U; Yin MB; Wilke H; Seeber S
J Clin Oncol; 1997 Jan; 15(1):389-400. PubMed ID: 8996166
[TBL] [Abstract][Full Text] [Related]
5. Future potential of thymidylate synthase inhibitors in cancer therapy.
Lehman NL
Expert Opin Investig Drugs; 2002 Dec; 11(12):1775-87. PubMed ID: 12457437
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of thymidylate synthase and glycinamide ribonucleotide transformylase.
Jackson RC
Adv Exp Med Biol; 1994; 370():179-83. PubMed ID: 7660885
[No Abstract] [Full Text] [Related]
7. Thymidylate synthase: a critical target in cancer therapy?
Rustum YM
Front Biosci; 2004 Sep; 9():2467-73. PubMed ID: 15353299
[TBL] [Abstract][Full Text] [Related]
8. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
[TBL] [Abstract][Full Text] [Related]
9. Anticancer antifolates: current status and future directions.
McGuire JJ
Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase: a critical target for cancer chemotherapy.
Rose MG; Farrell MP; Schmitz JC
Clin Colorectal Cancer; 2002 Feb; 1(4):220-9. PubMed ID: 12450420
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.
Van Triest B; Peters GJ
Oncology; 1999 Oct; 57(3):179-94. PubMed ID: 10545786
[TBL] [Abstract][Full Text] [Related]
12. The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.
Hernando-Cubero J; Matos-García I; Alonso-Orduña V; Capdevila J
J Gastrointest Cancer; 2017 Jun; 48(2):135-147. PubMed ID: 28397102
[TBL] [Abstract][Full Text] [Related]
13. New drugs in therapy of colorectal cancer: preclinical studies.
Rustum YM; Cao S
Semin Oncol; 1999 Dec; 26(6):612-20. PubMed ID: 10606254
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
15. Thymidylate synthase and drug resistance.
Peters GJ; van der Wilt CL; van Triest B; Codacci-Pisanelli G; Johnston PG; van Groeningen CJ; Pinedo HM
Eur J Cancer; 1995; 31A(7-8):1299-305. PubMed ID: 7577040
[TBL] [Abstract][Full Text] [Related]
16. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
17. Antifolates: the next millennium.
Allegra CJ
Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-2. PubMed ID: 10598548
[No Abstract] [Full Text] [Related]
18. Thymidylate synthase inhibitors.
Danenberg PV; Malli H; Swenson S
Semin Oncol; 1999 Dec; 26(6):621-31. PubMed ID: 10606255
[TBL] [Abstract][Full Text] [Related]
19. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
Gunasekara NS; Faulds D
Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase inhibition, a dead end?
Herrmann R
Eur J Cancer; 1995 Nov; 31A(12):1919-20. PubMed ID: 8562141
[No Abstract] [Full Text] [Related]
[Next] [New Search]